Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
Main Authors: | Bello Laura, Serrano Joaquín, López Soledad, Vázquez Pilar, Castro Ángeles, Mena Álvaro, Meijide Héctor, Pedreira José |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Retrovirology |
Similar Items
-
Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals
by: M.S. Carrillo, et al.
Published: (2017-12-01) -
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
by: Nicolò de Gennaro, et al.
Published: (2020-03-01) -
Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
by: Autumn D Zuckerman, et al.
Published: (2019-01-01) -
Difference in Markers of Microbial Translocation and Cell Apoptosis in HIV Monoinfected and HIV/HCV Coinfected Patients
by: Madelāne Monta, et al.
Published: (2019-08-01) -
Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
by: Yi Tan, et al.
Published: (2008-01-01)